Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 3,151-3,175 of 3,186
TerminatedNCT01100658

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 8 Years to 17 Years
Countries
United States
Sponsor
University of Minnesota
Condition
ADHD
CompletedNCT01862484

Neuroimaging of Diet in ADHD: Phase I

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 9 Years to 12 Years
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Condition
ADHD
CompletedNCT00506285

Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

ADHDOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Utah
Condition
ADHD
CompletedNCT01692782

Adult Attention Deficit Hyperactivity Disorder

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
CompletedNCT00360269

Atomoxetine Treatment for ADHD and Marijuana Dependence

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
ADHD
CompletedNCT00221962

Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

This study exists to understand whether the medication Aripiprazole is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication Aripiprazole can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 8 Years to 12 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
ADHD
CompletedNCT01338818

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

This study exists to understand how this type of care holds up over time after the earliest research stage. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

ADHDOtherFrom 18 Years to 60 Years
Countries
Belgium, Colombia, Denmark, Germany, Sweden, United States
Sponsor
Novartis Pharmaceuticals
Condition
ADHD
CompletedNCT01259492

Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether the medication Methylphenidate offers something meaningfully different. Researchers are trying to understand whether the medication Methylphenidate can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 60 Years
Countries
Belgium, Colombia, Denmark, Germany, Norway, Singapore, South Africa, Sweden, United States
Sponsor
Novartis Pharmaceuticals
Condition
ADHD
CompletedNCT01813669

Integrative Coping Group for Children

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.

ADHDOtherFrom 10 Years to 12 Years
Countries
United States
Sponsor
Duke University
Condition
ADHD
CompletedNCT00922636

A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

This study exists to better understand the safety of the medication Pediatric and how manageable it feels in practice. Researchers are trying to understand whether the medication Pediatric can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 17 Years
Countries
Canada, United States
Sponsor
Eli Lilly and Company
Condition
ADHD
CompletedNCT02215538

OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Utah
Condition
ADHD
CompletedNCT01177306

Inuniv and Working Memory

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 8 Years to 12 Years
Countries
United States
Sponsor
Lori A. Schweickert, MD
Condition
ADHD
CompletedNCT01127607

Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Florida International University
Condition
ADHD
CompletedNCT00612690

School-Based Mental Health Services for Urban Children

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

ADHDOtherFrom 5 Years to 12 Years
Countries
United States
Sponsor
University of Illinois at Chicago
Condition
ADHD
CompletedNCT02151396

Effect of Working Memory Training on ADHD Brain Function

This study exists to understand what helps brain scans or other body measurements work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 13 Years to 17 Years
Countries
United States
Sponsor
Hartford Hospital
Condition
ADHD
CompletedNCT00050050

Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder

This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
CompletedNCT00566449

A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder.

This study exists to compare options and see whether the medication JNJ-31001074 offers something meaningfully different. Researchers are trying to understand whether the medication JNJ-31001074 can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
ADHD